10 results on '"Rubin, M. Laura"'
Search Results
2. Factors Influencing Exercise Following Pancreatic Tumor Resection
- Author
-
Parker, Nathan H., Basen-Engquist, Karen, Rubin, M. Laura, Li, Yisheng, Prakash, Laura, Ngo-Huang, An, Gorzelitz, Jessica, Ikoma, Naruhiko, Lee, Jeffrey E., and Katz, Matthew H. G.
- Published
- 2021
- Full Text
- View/download PDF
3. Gender Bias in the Evaluation of Surgical Performance: Results of a Prospective Randomized Trial.
- Author
-
Antonoff, Mara B., Feldman, Hope, Luc, Jessica G. Y., Iaeger, Paula I., Rubin, M. Laura, Li, Liang, and Vaporciyan, Ara A.
- Abstract
Objective: The study aims to determine the influence of trainee gender on assessments of coronary anastomosis performance. Summary of Background Data: Understanding the impact of gender bias on the evaluation of trainees may enable us to identify and utilize assessment tools that are less susceptible to potential bias. Methods: Cardiothoracic surgeons were randomized to review the video performance of trainees who were described by either male or female pronouns. All participants viewed the same video of a coronary anastomosis and were asked to grade technique using either a Checklist or Global Rating Scale (GRS). Effect of trainee gender on scores by respondent demographic was evaluated using regression analyses. Inter-rater reliability was assessed using the Cronbach's alpha. Results: 103 cardiothoracic surgeons completed the Checklist (trainee gender: male n=50, female n=53) and 112 completed the GRS (trainee gender: male n=56, female n=56). For the Checklist, male cardiothoracic surgeons who were in practice <10 years (P = 0.036) and involved in training residents (P = 0.049) were more likely to score male trainees higher than female trainees. The GRS demonstrated high inter-rater reliability across male and female trainees by years and scope of practice for the respondent (alpha >0.900) when compared to the Checklist assessment tool. Conclusions: Early career male surgeons may exhibit gender bias against women when evaluating trainee performance of coronary anastomoses. The GRS demonstrates higher interrater reliability and robustness against gender bias in the assessment of technical performance than the Checklist, and such scales should be emphasized in educational evaluations. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. Clear Cell Chondrosarcoma: Clinical Characteristics and Outcomes in 15 Patients.
- Author
-
Flint, James H., Conley, Anthony P., Rubin, M. Laura, Feng, Lei, Lin, Patrick P., Moon, Bryan, Bird, Justin, Satcher, Robert L., and Lewis, Valerae O.
- Subjects
CANCER relapse ,CONFIDENCE intervals ,PUBLIC health surveillance ,SURVIVAL analysis (Biometry) ,SURVIVAL ,TREATMENT effectiveness ,PROPORTIONAL hazards models ,RETROSPECTIVE studies ,CHONDROSARCOMA ,DESCRIPTIVE statistics ,KAPLAN-Meier estimator - Abstract
Background. Clear cell chondrosarcoma (CCC) represents less than 6% of all chondrosarcomas, and thus, our understanding of this rare entity is limited. Analyzing clinical characteristics and treatment patterns, thus increasing our knowledge, may improve treatment strategy. We review our institutional experience with 15 patients, including one case with dedifferentiation. Methods. A retrospective review was conducted in CCC patients treated at our institution from 1996 to 2015, with at least 2-year follow-up. Descriptive statistics and Kaplan–Meier survival analyses were performed. Results. Of 19 patients identified, 15 patients had at least 2-year follow-up and were included. The median age at diagnosis was 43 years. 80% were male. The most common presenting signs were pain (12 patients; 80%) and fracture (2 patients; 13.3%). The most common site was proximal femur (8 patients; 53%). All patients had MSTS Stage I disease. Primary treatment included wide resection in 10 patients (67%) and intralesional or marginal resection in 5 patients (33%). Three patients died of disease during the study period, 1 with dedifferentiation of recurrent CCC. The median time to death from disease was 15.3 years (95% CI: (14.2; NA)). The median time to either recurrence or death was 7.73 years for patients who had intralesional/marginal resection and 16.44 years for patients with wide resection (HR (wide vs. intralesional/marginal) = 0.21, 95% CI: (0.04; 1.18), p = 0.053). The median time to recurrence or death was significantly shorter for patients not initially treated at a sarcoma center (p = 0.01). Conclusions. CCC is a rare entity, and our understanding of it is still evolving. We observed a higher recurrence rate for intralesional or marginal resection, and wide resection alone remains the mainstay of treatment. Better outcomes were observed in patients initially treated by trained musculoskeletal oncologists. Due to the propensity of CCC to recur decades after initial resection, lifelong surveillance is recommended. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
5. Association Between Multimodal Analgesia Administration and Perioperative Opioid Requirements in Patients Undergoing Head and Neck Surgery With Free Flap Reconstruction.
- Author
-
Vu, Catherine N., Lewis, Carol M., Bailard, Neil S., Kapoor, Ravish, Rubin, M. Laura, and Zheng, Gang
- Published
- 2020
- Full Text
- View/download PDF
6. Persistent and Chronic Postoperative Opioid Use in a Cohort of Patients with Oral Tongue Squamous Cell Carcinoma.
- Author
-
Cata, Juan P, Patino, Miguel, Gorur, Aysegul, Du, Kim N, Uhelski, Megan L, Myers, Jeffrey, Lai, Stephen, Rubin, M Laura, Dougherty, Patrick M, and Owusu-Agyemang, Pascal
- Subjects
THERAPEUTIC use of narcotics ,ANALGESICS ,CANCER patients ,COMBINED modality therapy ,LONGITUDINAL method ,ORAL surgery ,PAIN ,POSTOPERATIVE period ,SQUAMOUS cell carcinoma ,TONGUE diseases ,LOGISTIC regression analysis ,TONGUE tumors ,MULTIPLE regression analysis ,RETROSPECTIVE studies ,DESCRIPTIVE statistics - Abstract
Background Recently, the concept of persistent postsurgical opioid use has been described for patients undergoing cancer surgery. Our hypothesis was based on the premise that patients with oral tongue cancer require high dosages of opioids before, during, and after surgery, and thus a large percentage of patients might develop persistent postsurgical opioid use. Methods After institutional review board approval, we conducted a retrospective study that included a cohort of patients with oral tongue cancers who underwent curative-intent surgery in our institution. Multivariable logistic regression models were fit to study the association of the characteristics of several patients with persistent (six months after surgery) and chronic (12 months after surgery) postoperative opioid use. Results A total of 362 patients with oral tongue malignancies were included in the study. The rate of persistent use of opioids after surgery was 31%. Multivariate analysis showed that patients taking opioids before surgery and those receiving adjuvant therapy were 2.9 and 1.78 times more likely to use opioids six months after surgery. Fifteen percent of the patients were taking opioids 12 months after surgery. After adjusting for clinically relevant covariates, patients complaining of moderate tongue pain before surgery and those taking opioids preoperatively had at least three times higher risk of still using these analgesics one year after surgery. Conclusions Patients with oral tongue cancers have a high risk of developing persistent and chronic postsurgical opioid use. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
7. Prognosis of Six-Month Glasgow Outcome Scale in Severe Traumatic Brain Injury Using Hospital Admission Characteristics, Injury Severity Characteristics, and Physiological Monitoring during the First Day Post-Injury.
- Author
-
Rubin, M. Laura, Yamal, Jose-Miguel, Chan, Wenyaw, and Robertson, Claudia S.
- Subjects
- *
BRAIN injuries , *GLASGOW Coma Scale , *PATIENT monitoring , *HOSPITAL admission & discharge , *HOSPITAL utilization - Abstract
Gold standard prognostic models for long-term outcome in patients with severe traumatic brain injury (TBI) use admission characteristics and are considered useful in some areas but not for clinical practice. In this study, we aimed to build prognostic models for 6-month Glasgow Outcome Score (GOS) in patients with severe TBI, combining baseline characteristics with physiological, treatment, and injury severity data collected during the first 24 h after injury. We used a training dataset of 472 TBI subjects and several data mining algorithms to predict the long-term neurological outcome. Performance of these algorithms was assessed in an independent (test) sample of 158 subjects. The least absolute shrinkage and selection operator (LASSO) led to the highest prediction accuracy (area under the receiving operating characteristic curve = 0.86) in the test set. The most important post-baseline predictor of GOS was the best motor Glasgow Coma Scale (GCS) recorded in the first day post-injury. The LASSO model containing the best motor GCS and baseline variables as predictors outperformed a model with baseline data only. TBI patient physiology of the first day-post-injury did not have a major contribution to patient prognosis six months after injury. In conclusion, 6-month GOS in patients with TBI can be predicted with good accuracy by the end of the first day post-injury, using hospital admission data and information on the best motor GCS achieved during those first 24 h post-injury. Passed the first day after injury, important physiological predictors could emerge from landmark analyses, leading to prediction models of higher accuracy than the one proposed in the current research. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
8. Effect of Hemoglobin Transfusion Threshold on Cerebral Hemodynamics and Oxygenation.
- Author
-
Yamal, Jose-Miguel, Rubin, M. Laura, Benoit, Julia S., Tilley, Barbara C., Gopinath, Shankar, Hannay, H. Julia, Doshi, Pratik, Aisiku, Imoigele P., and Robertson, Claudia S.
- Subjects
- *
HEMOGLOBINS , *HEMODYNAMICS , *BLOOD pigments , *BLOOD circulation , *OXYGENATION (Chemistry) - Abstract
Cerebral dysfunction caused by traumatic brain injury may adversely affect cerebral hemodynamics and oxygenation leading to worse outcomes if oxygen capacity is decreased due to anemia. In a randomized clinical trial of 200 patients comparing transfusion thresholds <7 g/dl versus 10 g/dl, where transfusion of leukoreduced packed red blood cells was used to maintain the assigned hemoglobin threshold, no long-term neurological difference was detected. The current study examines secondary outcome measures of intracranial pressure (ICP), cerebral perfusion pressure (CPP), and brain tissue oxygenation (PbtO2) in patients enrolled in this randomized clinical trial. We observed a lower hazard for death (hazard ratio [HR]=0.12, 95% confidence interval [CI]=0.02-0.99) during the first 3 days post-injury, and a higher hazard for death after three days (HR=2.55, 95% CI=1.00-6.53) in the 10 g/dl threshold group as compared to the 7 g/dL threshold group. No significant differences were observed for ICP and CPP but MAP was slightly lower in the 7 g/dL group, although the decreased MAP did not result in increased hypotension. Overall brain tissue hypoxia events were not significantly different in the two transfusion threshold groups. When the PbtO2 catheter was placed in normal brain, however, tissue hypoxia occurred in 25% of patients in the 7 g/dL threshold group, compared to 10.2% of patients in the 10 g/dL threshold group ( p=0.04). Although we observed a few differences in hemodynamic outcomes between the transfusion threshold groups, none were of major clinical significance and did not affect long-term neurological outcome and mortality. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
9. Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial.
- Author
-
Robertson, Claudia S, Hannay, H Julia, Yamal, José-Miguel, Gopinath, Shankar, Goodman, J Clay, Tilley, Barbara C, Baldwin, Athena, Rivera Lara, Lucia, Saucedo-Crespo, Hector, Ahmed, Osama, Sadasivan, Santhosh, Ponce, Luciano, Cruz-Navarro, Jovanny, Shahin, Hazem, Aisiku, Imoigele P, Doshi, Pratik, Valadka, Alex, Neipert, Leslie, Waguspack, Jace M, and Rubin, M Laura
- Abstract
Importance: There is limited information about the effect of erythropoietin or a high hemoglobin transfusion threshold after a traumatic brain injury.Objective: To compare the effects of erythropoietin and 2 hemoglobin transfusion thresholds (7 and 10 g/dL) on neurological recovery after traumatic brain injury.Design, Setting, and Participants: Randomized clinical trial of 200 patients (erythropoietin, n = 102; placebo, n = 98) with closed head injury who were unable to follow commands and were enrolled within 6 hours of injury at neurosurgical intensive care units in 2 US level I trauma centers between May 2006 and August 2012. The study used a factorial design to test whether erythropoietin would fail to improve favorable outcomes by 20% and whether a hemoglobin transfusion threshold of greater than 10 g/dL would increase favorable outcomes without increasing complications. Erythropoietin or placebo was initially dosed daily for 3 days and then weekly for 2 more weeks (n = 74) and then the 24- and 48-hour doses were stopped for the remainder of the patients (n = 126). There were 99 patients assigned to a hemoglobin transfusion threshold of 7 g/dL and 101 patients assigned to 10 g/dL.Interventions: Intravenous erythropoietin (500 IU/kg per dose) or saline. Transfusion threshold maintained with packed red blood cells.Main Outcomes and Measures: Glasgow Outcome Scale score dichotomized as favorable (good recovery and moderate disability) or unfavorable (severe disability, vegetative, or dead) at 6 months postinjury.Results: There was no interaction between erythropoietin and hemoglobin transfusion threshold. Compared with placebo (favorable outcome rate: 34/89 [38.2%; 95% CI, 28.1% to 49.1%]), both erythropoietin groups were futile (first dosing regimen: 17/35 [48.6%; 95% CI, 31.4% to 66.0%], P = .13; second dosing regimen: 17/57 [29.8%; 95% CI, 18.4% to 43.4%], P < .001). Favorable outcome rates were 37/87 (42.5%) for the hemoglobin transfusion threshold of 7 g/dL and 31/94 (33.0%) for 10 g/dL (95% CI for the difference, -0.06 to 0.25, P = .28). There was a higher incidence of thromboembolic events for the transfusion threshold of 10 g/dL (22/101 [21.8%] vs 8/99 [8.1%] for the threshold of 7 g/dL, odds ratio, 0.32 [95% CI, 0.12 to 0.79], P = .009).Conclusions and Relevance: In patients with closed head injury, neither the administration of erythropoietin nor maintaining hemoglobin concentration of greater than 10 g/dL resulted in improved neurological outcome at 6 months. The transfusion threshold of 10 g/dL was associated with a higher incidence of adverse events. These findings do not support either approach in this setting.Trial Registration: clinicaltrials.gov Identifier: NCT00313716. [ABSTRACT FROM AUTHOR]- Published
- 2014
- Full Text
- View/download PDF
10. Enrollment of racially/ethnically diverse participants in traumatic brain injury trials: Effect of availability of exception from informed consent.
- Author
-
Yamal, Jose-Miguel, Robertson, Claudia S, Rubin, M Laura, Benoit, Julia S, Hannay, H Julia, and Tilley, Barbara C
- Subjects
ERYTHROPOIETIN ,ASIANS ,BLACK people ,BRAIN injuries ,CHI-squared test ,CONFIDENCE intervals ,EPIDEMIOLOGY ,ETHNIC groups ,FISHER exact test ,HISPANIC Americans ,INFORMED consent (Medical law) ,MINORITIES ,RACE ,RESEARCH funding ,STATISTICS ,T-test (Statistics) ,WHITE people ,WOUNDS & injuries ,DATA analysis ,GOVERNMENT regulation ,MULTIPLE regression analysis ,RANDOMIZED controlled trials ,HUMAN research subjects ,PATIENT selection ,RECEIVER operating characteristic curves ,DATA analysis software ,THERAPEUTICS - Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.